Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
59,119,327
-
Total 13F shares
-
41,268,115
-
Share change
-
+2,809,103
-
Total reported value
-
$428,365,693
-
Put/Call ratio
-
165%
-
Price per share
-
$10.38
-
Number of holders
-
101
-
Value change
-
+$24,120,588
-
Number of buys
-
44
-
Number of sells
-
50
Institutional Holders of Vanda Pharmaceuticals Inc. - Common Stock (VNDA) as of Q3 2014
As of 30 Sep 2014,
Vanda Pharmaceuticals Inc. - Common Stock (VNDA) was held by
101 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,268,115 shares.
The largest 10 holders included
FMR LLC, BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, Palo Alto Investors, LLC, PAULSON & CO INC, DEERFIELD MANAGEMENT CO, State Street Corp, KINGDON CAPITAL MANAGEMENT, L.L.C., Signpost Capital Advisors, LP, and BlackRock Fund Advisors.
This page lists
100
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.